UnitedHealth Group Stock Steadies Near $393 Amid Q2 Earnings Beat

UnitedHealth Group's stock has been steadily trading near $393 in early September 2026, as investors digest the company's strong second-quarter earnings beat and higher adjusted earnings outlook for 2026. The stock has seen a significant rise over the past year, but questions around margins and valuation remain.

The company reported adjusted earnings of $6.38 per share for the second quarter of 2026, beating the consensus estimate by roughly 30 percent. This outperformance underscores the company's earnings power in its health insurance and Optum platforms.

UnitedHealth Group also raised its full-year 2026 adjusted EPS guidance to a range of $19.50 to $20.00 per share, implying double-digit earnings growth versus 2025. The company doubled its planned 2026 share buyback authorization from at least $2.5 billion to at least $5 billion, signaling confidence in cash generation and balance sheet strength.

Analysts have moved their 2026 EPS expectations toward management's new range, with the average estimate now standing at $19.82 per share, up $1.53 over the last 60 days. The stock trades at a price of roughly $393 per share, which equates to around 19.8 times the earnings analysts expect for 2026.